Clinical Research Directory
Browse clinical research sites, groups, and studies.
Registry Platform Myelofibrosis and Anemia
Sponsor: iOMEDICO AG
Summary
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease and to collect patient-reported outcomes for patients with primary and secondary myelofibrosis and anemia in Germany.
Official title: Clinical Research Platform on Treatment, Quality of Life and Outcome of Patients With Primary and Secondary Myelofibrosis and Anemia Who Are JAK Inhibitor Treatment-naïve or JAK Inhibitor Treatment-experienced (RHODOLITE)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
200
Start Date
2026-02-19
Completion Date
2031-09
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Locations (1)
Multiple sites all over Germany
Multiple Locations, Germany